Background: Malposition of percutaneously inserted chest tubes is considered as a rare complication in critically ill patients. Its incidence, however, remains uncertain. The aims of the study were to assess the true incidence of chest tube malposition in critically ill patients and to identify predicting factors.
Methods: The authors prospectively studied 122 chest tubes percutaneously inserted in 75 consecutive critically ill patients. For clinical reasons independent of the study, thoracic computed tomography scanning was performed in 63 patients, allowing direct visualization of 106 chest tubes. Based on these findings, chest tube position was classified as intrapleural, intrafissural, or intraparenchymal. Factors predicting chest tube malposition were analyzed by univariate and multivariate analysis.
Results: The mean delay between chest tube placement and thoracic scan was 3.5 +/- 2.9 days. Twenty-two chest tubes were diagnosed as being intrafissural (21%), and 10 were diagnosed as being intraparenchymal (9%). The only predicting factor associated with the risk of malposition was the use of a trocar for the percutaneous insertion of the chest tube (P = 0.032). 相似文献
A combination of levonorgestrel 0.15mg and
ethinyl estradiol 0.03mg, an ultra-low dose oral con
traceptive in pellet form, was tried out in 9 Beijing
clinics. A total of l,035 healthy women of reproduc
tive age participated in 9,413 cycles of treatment.
Only one pregnancy was attributed to medication
failure which resulted in a corrected Pearl index of
0.13/100 women-year. The incidence of breakthrough
bleeding and amenorrhea was 0.12% and 0.05% res
pectively. Using the life-table method, the net
cumulative rate of termination due to medical-related
reasons at one year was only 5.93/100 women. The
incidence of side effects was low. The most frequent
complaints were nausea and drowsiness, which re
duced with the increase of treatment cycles. Some
metabolic changes were studied. In comparison
with other OCs used in China, this formula has the
advantages of ultra-low-dose steroids with higher
contraceptive efficacy, better cycle control and
fewer side effects. 相似文献